In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Survey Finds Few Japanese Use Contact Lenses Containing High Oxygen

This article was originally published in PharmAsia News

Executive Summary

J&J Japanese subsidiary, Tokyo-based J&J Vision Care Company, released survey results from 500 Japanese contact lens users, which found that although roughly 50 percent of respondents acknowledged that lack of oxygen could cause eye disorders, only 10 percent use high oxygen-containing contact lenses. The survey also found that 51 percent of users are aware of appropriate vision care. Among these people, 44 percent take regular breaks and 34 percent use eye drops. In terms of contact lens use, 20 percent wear them according to intended use times, 17 percent use contact lenses that are more comfortable to the eyes. (Click here for more - Japanese language

You may also be interested in...



EMA's Decision On Ranitidine Remaining Available Could Come At End Of April

Following the US request for ranitidine drugs to be withdrawn from the market, the European Medicines Agency says it would decide the fate of the products in the EU after wrapping up its own inquiry.

Perrigo Has Approval For Copy Of OTC Voltaren Arthritis Relief Before GSK Launches The Brand

Perrigo will launch generics of GSK's OTC Voltaren Arthritis Pain drug later in 2020 following FDA approval of its ANDA. GSK, which received FDA's OTC switch approval in February, still hasn't launched the product or indicated when it will.

2020 US Beauty May Be Headed For Record Declines, But There Are COVID-19 Opportunities

Kline & Company’s worst-case scenario – which it says is looking more and more likely – has the US cosmetics and personal-care market declining by as much as 8.1% in 2020. However, Kline, Mintel and other market intelligence firms say there are opportunities available to companies struggling to weather the COVID-19 storm.

UsernamePublicRestriction

Register

SC072000

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel